Differential susceptibility of renal carcinoma cell lines to tumor suppression by exogenous Fhit expression

Cancer Research

Volumn 60, Issue 11, 2000, Pages 2780-2785

  Werner, Nicole Susann ^a   Siprashvili, Zurab ^b   Fong, Louise Y Y ^b   Marquitan, Guido ^a   Schröder, Jan K ^a   Bardenheuer, Walter ^a   Seeber, Siegfried ^a   Huebner, Kay ^b   Schütte, Jochen ^a   Opalka, Bertram ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER CELL CULTURE; CHROMOSOME 3P; GENE DELETION; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

ACID ANHYDRIDE HYDROLASES; ANIMALS; BLOTTING, WESTERN; CARCINOMA, RENAL CELL; CELL CYCLE; CHROMOSOMES, HUMAN, PAIR 3; DNA, COMPLEMENTARY; DOWN-REGULATION; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; MICE; MICE, NUDE; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; PROTEINS; SUPPRESSION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0034213711     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Devilee, P., van den Broek, M., Kuipers-Dijkshoom, N., Kolluri, R., Khan, P. M., Pearson, P. L., and Cornelisse, C. J. At least four different chromosomal regions are involved in loss of heterozygosity in human breast carcinoma. Genomics, 5: 554-560, 1989.
2. Hibi, K., Takahashi, T., Yamakawa, K., Ueda, R., Sekido, Y., Ariyoshi, Y., Suyama, M., Takagi, H., Nakamura, Y., and Takahashi, T. Three distinct regions involved in 3p deletion in human lung cancer. Oncogene, 7: 445-449, 1992.
3. Lubinski, J., Hadaczek, P., Podolski, J., Toloczko, A., Sikorski, A., McCue, P., Druck, T., and Huebner, K. Common regions of deletion in chromosome regions 3p12 and 3p14.2 in primary clear cell renal carcinomas. Cancer Res., 54: 3710-3713, 1994.
4. van den Berg, A., and Buys, C. H. C. M. Involvement of multiple loci on chromosome 3 in renal cell cancer development. Genes Chromosomes Cancer, 19: 59-76, 1997.
5. Zbar, B., Brauch, H., Talmadge, C., and Linehan, M. Loss of alleles of loci on the short arm of chromosome 3 in renal cell carcinoma. Nature (Lond.), 327: 721-724, 1987.
6. Chen, F., Kishida, T., Duh, F. M., Renbaum, P., Orcutt, M. L., Schmidt, L., and Zbar, B. Suppression of growth of renal carcinoma cells by the von Hippel-Lindau tumor suppressor gene. Cancer Res., 55: 4804-4807, 1995.
7. Sanchez, Y., el-Naggar, A., Pathak, S., and Killary, A. M. A tumor suppressor locus within 3p14-p12 mediates rapid cell death of renal cell carcinoma in vivo. Proc. Natl. Acad. Sci. USA, 91: 3383-3387, 1994.
8. Lott, S. T., Lovell, M., Naylor, S. L., and Killary, A. M. Physical and functional mapping of a tumor suppressor locus for renal cell carcinoma within chromosome 3p12. Cancer Res., 58: 3533-3537, 1998.
9. Lovell, M., Lott, S. T., Wong, P., El-Naggar, A., Tucker, S., and Killary, A. M. The genetic locus NRC-1 within chromosome 3p12 mediates tumor suppression in renal cell carcinoma independently of histological type, tumor microenvironment, and VHL mutation. Cancer Res., 59: 2182-2189, 1999.
10. Jülicher, K., Marquitan, G., Werner, N., Bardenheuer, W., Vieten, L., Bröcker, F., Topal, H., Seeber, S., Opalka, B., and Schütte, J. Novel tumor suppressor locus in human chromosome region 3p14.2. J. Natl. Cancer Inst., 91: 1563-1568, 1999.
11. Olson, D. J., Oshimura, M., Otte, A. P., and Kumar, R. Ectopic expression of wnt-5a in human renal cell carcinoma cells suppresses in vitro growth and telomerase activity. Tumour Biol., 19: 244-252, 1998.
12. Tanaka, H., Shimizu, M., Horikawa, I., Kugoh, H., Yokota, J., Barrett, J. C., and Oshimura, M. Evidence for a putative telomerase repressor gene in the 3p14.2-p21.1 region. Genes Chromosomes Cancer, 23: 123-133, 1998.
13. Cuthbert, A. P., Bond, J., Trott, D. A., Gill, S., Broni, J., Marriott, A., Khoudoli, G., Parkinson, E. K., Cooper, C. S., and Newbold, R. F. Telomerase repressor sequences on chromosome 3 and induction of permanent growth arrest in human breast cancer cells. J. Natl. Cancer Inst., 91: 37-45, 1999.
14. Ohta, M., Inoue, H., Cotticelli, M. G., Kastury, K., Baffa, R., Palazzo, J., Siprashvili, Z., Mori, M., McCue, P., Druck, T., Croce, C. M., and Huebner, K. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell, 84: 587-597, 1996.
15. Druck, T., Hadaczek, P., Fu, T. B., Ohla, M., Siprashvili, Z., Baffa, R., Negrini, M., Kastury, K., Veronese, M. L., Rosen, D., Rothstein, J., McCue, P., Cotticelli, M. G., Inoue, H., Croce, C. M., and Huebner, K. Structure and expression of the human FHIT gene in normal and tumor cells. Cancer Res., 57: 504-512, 1997.
16. Bugert, P., Wilhelm, M., and Kovacs, G. FHIT gene and the FRA3B region are not involved in the genetics of renal cell carcinomas. Genes Chromosomes Cancer, 20: 9-15, 1997.
17. Velickovic, M., Delahunt, B., and Grebe, S. K. G. Loss of heterozygosity at 3p14.2 in clear cell renal cell carcinoma is an early event and is highly localized to the FHIT gene locus. Cancer Res., 59: 1323-1326, 1999.
18. Hadaczek, P., Siprashvili, Z., Markiewski, M., Domagala, W., Druck, T., McCue, P. A., Pekarsky, Y., Ohta, M., Huebner, K., and Lubinski, J. Absence or reduction of Fhit expression in most clear cell renal carcinomas. Cancer Res., 58: 2946-2951, 1998.
19. Eyzaguirre, E. J., Miettinen, M., Norris, B. A., and Gatalica, Z. Different immunohistochemical patterns of Fhit protein expression in renal neoplasms. Mod. Pathol., 12: 979-983, 1999.
20. Ji, L., Fang, B., Yen, N., Fong, K., Minna, J. D., and Roth, J. A. Induction of apoptosis and inhibition of tumorigenicity and tumor growth by adenovirus vector-mediated fragile histidine triad (FHIT) gene overexpression. Cancer Res.., 59: 3333-3339, 1999.
21. Sard, L., Accornero, P., Tornielli, S., Delia, D., Bunone, G., Campiglio, M., Colombo, M. P., Gramegna, M., Croce, C. M., Pierotti, M. A., and Sozzi, G. The tumor-suppressor gene FHIT is involved in the regulation of apoptosis and cell cycle control. Proc. Natl. Acad. Sci. USA, 96: 8489-8492, 1999.
22. Siprashvili, Z., Sozzi, G., Barnes, L. D., McCue, P., Robinson, A. K., Eryomin, V., Sard, L., Tagliabue, E., Greco, A., Fusetti, L., Schwanz, G., Pierotti, M. A., Croce, C. M., and Huebner, K. Replacement of Fhit in cancer cells suppresses tumorigenicity. Proc. Natl. Acad. Sci. USA, 94: 13771-13776, 1997.
23. Wu, R., Connolly, D. C., Dunn, R. L., and Cho, K. R. Restored expression of fragile histidine triad protein and tumorigenicity of cervical carcinoma cells. J. Natl. Cancer Inst., 92: 338-344, 2000.
24. Otterson, G. A., Xiao, G-H., Geradts, J., Jin, F., Chen, W-D., Niklinska, W., Kaye, F. J., and Yeung, R. S. Protein expression and functional analysis of the FHIT gene in human tumor cells. J. Natl. Cancer Inst., 90: 426-432, 1998.
25. Naito, S., von Eschenbach, A. C., Giavazzi, R., and Fidler, I. J. Growth and metastasis of tumor cells isolated from a human renal cell carcinoma implanted into different organs of nude mice. Cancer Res., 46: 4109-4115, 1986.
26. Schattk, S., Decken, K., Schmitz-Dräger, B., Ackermann, R., and Ebert, T. Establishment and characterization of human renal cancer cell lines and autologous normal kidney short term cultures. Investig. Urol., 5. 35-41, 1994.
27. Jülicher, K., Vieten, L., Bröcker, F., Bardenheuer, W., Schütte, J., and Opalka, B. Yeast artificial chromosome transfer into human renal carcinoma cells by spheroplast fusion. Genomics, 43: 95-98, 1997.
28. Barnes, L. D., Garrison, P. N., Siprashvili, Z., Guranowski, A., Robinson, A. K., Ingram, S. W., Croce, C. M., Ohta, M., and Huebner, K. Fhit, a putative tumor suppressor in humans, is a dinucleoside 5′,5‴-P1,P3-triphosphate hydrolase. Biochemistry, 35: 11529-11535, 1996.
29. Clifford, S. C., Prowse, A. H., Affara, N. A., Buys, C. H. C. M., and Maher, E. R. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis. Genes Chromosomes Cancer, 22: 200-209, 1998.